Delay in treatment of adult hemophagocytic lymphohistiocytosis is associated with worse in-hospital outcomes

[1]  A. Belot,et al.  Anakinra for the Treatment of Hemophagocytic Lymphohistiocytosis: 21 Cases , 2022, Journal of clinical medicine.

[2]  J. Panse,et al.  Hemophagocytic lymphohistiocytosis in adults: collaborative analysis of 137 cases of a nationwide German registry , 2020, Journal of Cancer Research and Clinical Oncology.

[3]  R. Cron,et al.  Benefit of Anakinra in Treating Pediatric Secondary Hemophagocytic Lymphohistiocytosis , 2020, Arthritis & rheumatology.

[4]  K. Nichols,et al.  Recommendations for the management of hemophagocytic lymphohistiocytosis in adults. , 2019, Blood.

[5]  C. Eby,et al.  Transfusion requirements and 30-day mortality predictors for adult hemophagocytic lymphohistiocytosis , 2018, International Journal of Hematology.

[6]  Scott Montgomery,et al.  Confirmed efficacy of etoposide and dexamethasone in HLH treatment: long-term results of the cooperative HLH-2004 study. , 2017, Blood.

[7]  S. Aleem,et al.  A Personalized Diagnostic and Treatment Approach for Macrophage Activation Syndrome and Secondary Hemophagocytic Lymphohistiocytosis in Adults , 2017, Journal of Clinical Immunology.

[8]  D. Giustini,et al.  Hemophagocytic syndromes (HPSs) including hemophagocytic lymphohistiocytosis (HLH) in adults: A systematic scoping review. , 2016, Blood reviews.

[9]  C. Eby,et al.  Clinical characteristics, prognostic factors, and outcomes of adult patients with hemophagocytic lymphohistiocytosis , 2015, American journal of hematology.

[10]  A. López-Guillermo,et al.  Adult haemophagocytic syndrome , 2014, The Lancet.

[11]  Shaji K. Kumar,et al.  Prognostic factors and outcomes of adults with hemophagocytic lymphohistiocytosis. , 2014, Mayo Clinic proceedings.

[12]  M. Alvarez,et al.  Hemophagocytic syndrome in patients with acute myeloid leukemia undergoing intensive chemotherapy , 2014, Haematologica.

[13]  A. Filipovich,et al.  Salvage therapy of refractory hemophagocytic lymphohistiocytosis with alemtuzumab , 2013, Pediatric blood & cancer.

[14]  R. Egeler,et al.  Chemoimmunotherapy for hemophagocytic lymphohistiocytosis: long-term results of the HLH-94 treatment protocol. , 2011, Blood.

[15]  A. Filipovich,et al.  How I treat hemophagocytic lymphohistiocytosis. , 2011, Blood.

[16]  J. Lucas,et al.  Secondary hemophagocytic syndrome in adults: a case series of 18 patients in a single institution and a review of literature , 2011, Hematological oncology.

[17]  M. Aricò,et al.  HLH‐2004: Diagnostic and therapeutic guidelines for hemophagocytic lymphohistiocytosis , 2007, Pediatric blood & cancer.

[18]  C. Kooperberg,et al.  Comparison of self-report, hospital discharge codes, and adjudication of cardiovascular events in the Women's Health Initiative. , 2004, American journal of epidemiology.

[19]  M. Kato,et al.  Requirement for etoposide in the treatment of Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis. , 2001, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.